摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4S)-1,1-Dimethylethyl 4-<(E)-3'-methoxy-3'-oxo-1'-propenyl>-2,2-dimethyl-3-oxazolidinecarboxylate | 129483-65-4

中文名称
——
中文别名
——
英文名称
(4S)-1,1-Dimethylethyl 4-<(E)-3'-methoxy-3'-oxo-1'-propenyl>-2,2-dimethyl-3-oxazolidinecarboxylate
英文别名
tert-butyl (4S)-4-[(1E)-3-methoxy-3-oxoprop-1-enyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate;methyl (E)-3-[(4'S)-N-tert-butoxycarbonyl-2',2'-dimethyloxazolidin-4'-yl]propenoate;tert-butyl (4S)-4-[(1E)-3-methoxy-3-oxoprop-1-en-1-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate;(S)-tert-Butyl4-(3-methoxy-3-oxoprop-1-en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate;tert-butyl (4S)-4-[(E)-3-methoxy-3-oxoprop-1-enyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
(4S)-1,1-Dimethylethyl 4-<(E)-3'-methoxy-3'-oxo-1'-propenyl>-2,2-dimethyl-3-oxazolidinecarboxylate化学式
CAS
129483-65-4
化学式
C14H23NO5
mdl
——
分子量
285.34
InChiKey
YSNYRLFAMVTFTM-JARNTUPDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    368.4±42.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    65.1
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Total Synthesis of TMC-95A and -B via a New Reaction Leading to <i>Z</i>-Enamides. Some Preliminary Findings as to SAR
    作者:Songnian Lin、Zhi-Qiang Yang、Benjamin H. B. Kwok、Michael Koldobskiy、Craig M. Crews、Samuel J. Danishefsky
    DOI:10.1021/ja049821k
    日期:2004.5.1
    A full account of the total syntheses of proteasome inhibitors TMC-95A and -B is provided. A key feature of the syntheses involved installation of a cis-propenylamide moiety by a thermal rearrangement of an alpha-silylallyl amide. The scope and mechanism of the enamide-forming reaction are discussed. Also provided are some preliminary results from SAR studies. It was found that simplified analogues
    提供了蛋白酶体抑制剂 TMC-95A 和 -B 的全合成的完整说明。合成的一个关键特征涉及通过α-甲硅烷基烯丙基酰胺的热重排安装顺式丙烯酰胺部分。讨论了烯酰胺形成反应的范围和机理。还提供了一些 SAR 研究的初步结果。发现简化的类似物可以保留蛋白酶体抑制的全部效力。
  • 1,2-Diastereoselective C-C Bond-Forming Reactions for the Synthesis of Chiral β-Branched α-Amino Acids
    作者:Thomas Spangenberg、Angèle Schoenfelder、Bernhard Breit、André Mann
    DOI:10.1002/ejoc.201000865
    日期:2010.11
    S N 2' sequences have been employed for the synthesis of β-branched α-amino acids using 1,2-diastereocontrol for forming C―C bonds. An oxazolidine fragment derived from Garner's aldehyde provides the handle for facial discrimination and acts as a masked amino acid functionality. This study encompasses directed and non-directed allylic substitution reactions. The stereocontrol of the oxazolidine appendage
    SN 2' 序列已用于合成 β-支链 α-氨基酸,使用 1,2-非对映控制形成 C-C 键。来自 Garner 醛的恶唑烷片段提供了面部识别的手柄,并充当了掩蔽的氨基酸功能。该研究包括定向和非定向烯丙基取代反应。还研究了末端烯烃加氢甲酰化过程中恶唑烷附属物的立体控制。公开了了解反应的非对映化学结果以及合成应用的努力。
  • A New Method for the Synthesis of Chiral β-Branched α-Amino Acids
    作者:Thomas Spangenberg、Angèle Schoenfelder、Bernhard Breit、André Mann
    DOI:10.1021/ol071305m
    日期:2007.9.1
    A new method for the synthesis of chiral beta-branched alpha-amino acids based on a copper-mediated directed allylic substitution reaction with Grignard reagents is reported. This is the first case in which a delta-stereogenic center is controlling the diastereoselectivity of an o-DPPB-directed allylic substitution. Depending on the alkene geometry of the starting material either diastereomer, anti
    报道了一种基于铜与格氏试剂的定向的烯丙基取代反应合成手性β-支链α-氨基酸的新方法。这是δ-立体异构中心控制o-DPPB定向的烯丙基取代的非对映选择性的第一种情况。取决于起始原料的烯烃几何形状,可以以良好水平的无环立体控制来获得非对映异构体,反异构体或顺式异构体。
  • [EN] AMINOCYCLOHEXANES AND AMINOTETRAHYDROPYRANS AND RELATED COMPOUNDS AS GAMMA-SECRETASE MODULATORS<br/>[FR] AMINOCYCLOHEXANES ET AMINOTÉTRAHYDROPYRANES ET COMPOSÉS ASSOCIÉS COMME MODULATEURS DE GAMMA-SÉCRÉTASE
    申请人:PFIZER
    公开号:WO2011092611A1
    公开(公告)日:2011-08-04
    Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    本发明揭示了化合物及其在规范中定义的结构为式(I)的药学上可接受的盐。同时还公开了相应的药物组合物、治疗方法、合成方法和中间体。
  • Stereocontrolled Synthesis of the Northern Part of Potent Proteasome Inhibitor TMC-95A
    作者:Masayuki Inoue、Hidetomo Furuyama、Hayato Sakazaki、Masahiro Hirama
    DOI:10.1021/ol016303v
    日期:2001.9.1
    [reaction: see text]. A protected version of the northern part of TMC-95A, a potent and selective proteasome inhibitor, was synthesized with full stereochemical control. Highlights of this synthesis include (i) a (Z)-selective Mizoroki-Heck reaction to construct the oxyindole portion, (ii) a diastereoselective epoxidation, (iii) a 6-endo selective epoxide opening by Boc carbonyl group to establish
    [反应:请参见文字]。在完全的立体化学控制下合成了TMC-95A北部的保护版本,TMC-95A是一种有效的选择性蛋白酶体抑制剂。该合成的重点包括(i)(Z)选择性Mizoroki-Heck反应以构建羟吲哚部分,(ii)非对映选择性环氧化,(iii)由Boc羰基形成的6-内酯选择性环氧化物以建立立体异构C6和(iv)在Mitsunobu条件下L-al-苏氨酸衍生物的1,3-消除反应,得到(Z)-1-丙烯胺。
查看更多